Most Clicked StoriesMore >


New guidelines recommend Novartis' heart failure drug

ASNC SmartBrief | May 25, 2016

Novartis' Entresto, or sacubitril/valsartan, received a Class I recommendation for treatment of heart failure in newly issued guidelines from the American College of Cardiology, the American Heart Association and the European Society of Cardiology. According to the guidelines, patients who can tolerate standard treatments and have sufficient blood pressure should be given Entresto instead of ACE inhibitors and angiotensin II receptor blockers. RTT News (05/21) Reuters (05/21)


Study validates software gating for PET

ASNC SmartBrief | May 23, 2016

Intensive hypertension treatment lowers seniors' risk of heart problems

ASNC SmartBrief | May 25, 2016

Study: Women with AFib more likely to survive than men

ASNC SmartBrief | May 23, 2016

ASNC announces 2016 QCDR designation for ImageGuide Registry

ASNC SmartBrief | May 25, 2016

Novartis hopes new clinical trial data will boost flagging sales of Entresto

ASNC SmartBrief | May 23, 2016

Just released: New Chinese translation of the single photon emission computed technology (SPECT) guideline

ASNC SmartBrief | May 25, 2016

Study: Statin use has no impact on CV risk in women with diabetes

ASNC SmartBrief | May 23, 2016

Study: Close to 25% of heart attack patients get heart failure

ASNC SmartBrief | May 25, 2016

Daytime naps tied to elevated hypertension risk

ASNC SmartBrief | May 25, 2016


Find ASNC SmartBrief Issues by Date:



ASNC News More >


ASNC announces 2016 QCDR designation for ImageGuide Registry

ASNC SmartBrief | May 25, 2016

Just released: New Chinese translation of the single photon emission computed technology (SPECT) guideline

ASNC SmartBrief | May 25, 2016

Take ASNC's Nuclear Cardiology Choosing Wisely® Challenge

ASNC SmartBrief | May 23, 2016

Just published: HCP-LAN white paper on Coronary Artery Disease payment models

ASNC SmartBrief | May 23, 2016

Invitation from ASNC2016 Program Chair

ASNC SmartBrief | May 18, 2016




Sign up for ASNC SmartBrief



Designed specifically for nuclear cardiology professionals, ASNC SmartBrief is a FREE weekly e-mail newsletter. It keeps you up to date on industry news, developments, and new technology. Learn more

Recent Poll view more polls


How often do patients ask about radiation risks?

Chart.